JAMP Pharma Corporation is recalling its digoxin tablets because some bottles may contain an incorrect dose, Health Canada announced in an advisory. The drug-maker said its 0.0625 and 0.125 mg digoxin ...

Digoxin was shown to be dangerous at high levels for atrial fibrillation (Afib) patients in a randomized trial. Meanwhile, another study suggested the benefit of genotyping for better warfarin ...

Researchers at the University of Illinois at Chicago have taken the dangerous guesswork out of dosing a life-saving medication for congestive heart failure. Researchers at the University of Illinois ...

Recommendations for digoxin use in patients with HF have changed only slightly with the 2005 guidelines. [1] The primary change was to reclassify the recommendation for use from Class I, evidence ...

Most of the estimated 400 000 Canadians who experience heart failure are 65 years of age or older. Heart failure is the most frequent reason for hospital admission for older adults. Admission for ...

Use lower end of dosing 0. In heart failure, higher dosages have no additional benefit and may increase toxicity; decreased renal order lanoxin digoxin may lead to increased toxicity. Very narrow ...

In patients with heart failure with reduced ejection fraction (HFrEF) who have an implantable cardioverter-defibrillator (ICD), the use of digoxin may increase the risk of ventricular tachyarrhythmia ...

Paladin Labs Inc. has announced the Canadian launch of DigiFab™ Digoxin Immune Fab (Ovine). DigiFab™ is indicated for the treatment of patients with life-threatening or potentially life-threatening ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. A monitor is seen ...